Abiopharma

🔍 Marion Elaine D (Executive)

Company: EPLUS INC (PLUS)

Report Date: 2026-06-14

Detailed Transactions and Holdings:

• Sold 2,742 shares of Common Stock at $83.19 per share (Direct)
  Date: 2026-06-14 | Code: F | equity_swap_involved: false | shares_owned_after: 34,373.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,792 shares of Common Stock at $83.19 per share (Direct)
  Date: 2026-06-14 | Code: F | equity_swap_involved: false | shares_owned_after: 31,581.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-14 | Code: H | nature_of_ownership: By Elaine D. Marion Trust | shares_owned_after: 78,621.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-14 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 424.00

Footnotes:

• F1: Represents shares withheld for payment of tax liability arising as a result of the partial vesting of a restricted stock award granted on June 14, 2023, and originally reported by the reporting person in a Form 4 filed with the Commission on June 16, 2023.
• F2: Represents shares withheld for payment of tax liability arising as a result of the partial vesting of a restricted stock award granted on June 14, 2024, and originally reported by the reporting person in a Form 4 filed with the Commission on June 18, 2024.
• F3: The shares are held in a revocable trust, of which the reporting person and her spouse are the sole trustees and beneficiaries.